{"name":"ABM Therapeutics Corporation","slug":"abm-therapeutics-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE4xMHVKU1RITHdrZjVaUW1md05BUnU3UzhLMG82YXJHUWtDYnpMTDFEU051UjVWVlFDLTcyb3dpQTZQcTVnempQbmM0ekhjeVBPVlp2NDJyMHl1QllIR3ZF?oc=5","date":"2026-01-13","type":"trial","source":"nature.com","summary":"Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson - nature.com","headline":"Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8wFBVV95cUxOM0ZhWjFHeTNCQnJCY0Y2dGo2SDhmTjhqZWMzNlZ0d0JOOWcwVk4yd2o2RUxqN1FRWXJwNllqX2FPaHRneXUzVlhZYlFhZXVZNEJaMy0xNFJnSjAwdVNiNVF6SnFNSkZGeWdSZXlxRzA1dzVMa1NvUmk0c0wwMmdueE1RSUdzV0UtT0toZ1ZrTmV1QUdvSExYMGh0Sl9PYzU2UmhQQjNNakEtSW84ZUJHNHR1cTUzUEtUbGpQTU11NVpQNlNFLTlqZEc4OC1lNDNiNkFfN3RDT0IzRWFCZHFFdXBiZnJFT0VpQU5CS19BdVNYcDA?oc=5","date":"2025-06-17","type":"pipeline","source":"PR Newswire","summary":"ABM Respiratory Care Closes $14.8M Oversubscribed Series B to Accelerate Commercialization of BiWaze® Clear - PR Newswire","headline":"ABM Respiratory Care Closes $14.8M Oversubscribed Series B to Accelerate Commercialization of BiWaze® Clear","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE1wY04wUHpRWFVrTnBfOVBoSnVjTkRxMUhQT056dnR2bkhwNWhJaGk0a0ViZ1M1anFXT0pSY0lLNXItc0FWS1RIMkpuc1RxUlFJSkJpS2pyY19SaVhJaHlMallkeGRscU1lOE1N?oc=5","date":"2025-02-13","type":"trial","source":"Wiley Online Library","summary":"A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma - Wiley Online Library","headline":"A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTFAta0U2N3FIN0k4em5rcHdpNGdaS3BjSWRVVHZqTWt5ZExDTEFRWUlXbS1Cd29CbFRHMVlqS2xSaWttWjdiT19idlB1elRMYWxJMVhfRl9kT0I1dEVJU3NmcjNaY3VKVHhDczFmeWFYSE1Ianh2bnJuSVdXRQ?oc=5","date":"2025-01-23","type":"trial","source":"Wiley","summary":"A phase 2 basket study of talabostat, a small-molecule inhibitor of dipeptidyl peptidases, administered in combination with pembrolizumab in patients with advanced solid cancers - Wiley","headline":"A phase 2 basket study of talabostat, a small-molecule inhibitor of dipeptidyl peptidases, administered in combination w","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE52YndCeDNJYXJJLUNOcnFIMkZ3R3lwdzd0MW5ZeGRld1RFeXEycmpCS2xFX0Y1V0JMRUNyNmJtNjlCT2RZLXlXV2JzRjhNam43VzgxNno1djdFVFZHcFpVTWxmaWhPMHVBSnc?oc=5","date":"2024-02-24","type":"trial","source":"Wiley Online Library","summary":"Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumors - Wiley Online Library","headline":"Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced sol","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNS1JUdnlRUkMxUFZQUFl4LXVvZUJ3TVhXTkdZbUhINUZlZlJrZjl0TmFyaldVWGpWVlJPQ25xYWpqU2hDblNJdGVLd01rTFcyQWUwR1JqZERQZXg1emJ3d3dYdWlxRGdDWjJWR1dmd19xaVI5cV92d3NTYnF2dWF3MDZSNUZ0TDY3MXJxNUlwUWhWMVFNWU9Mc3FFUnJ0Y19TekZNdmVxWng?oc=5","date":"2022-12-27","type":"pipeline","source":"The Healthcare Technology Report.","summary":"The Top 25 Healthcare Technology Leaders of Vancouver for 2022 - The Healthcare Technology Report.","headline":"The Top 25 Healthcare Technology Leaders of Vancouver for 2022","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOMUZCVFl0WWEyODluWUdNSzI1QWptbTJVQzgyR1o0TmhVQnJrTDdhWDk5eUxXc2ltMVRncUJhMmtvci1Cdjl1ZV9SZzBVVS1oUHBlVm1GT09oMG5YZUpuSVhyM09PZmthbkFDZzN2X2ZJRDYzMEV2X3pDWndQTXlGNjkteGhBNXlIcHlIYlhmRmhNQQ?oc=5","date":"2022-11-23","type":"pipeline","source":"Yahoo Finance","summary":"Extremely Robust Brain Metastases Pipeline Featuring 45+ Companies Expected to Change the Pace of the Brain Metastases Treatment | DelveInsight - Yahoo Finance","headline":"Extremely Robust Brain Metastases Pipeline Featuring 45+ Companies Expected to Change the Pace of the Brain Metastases T","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxPY1ZOZS1SeDJvZ1FtczVCREl1ZFVqclNJNEZaZHg5VGJLR3EtRzI2eXNwTmM2X0JrcjdZNThyeDlqejdnUjNGdnpZSzJHcGNTRlEtUjUwajNuTlhMS3lKMVF5YmdHYW8zc3NMWlBkeVhsdTBkSGI1NE1BV0o5WnBtWG5pNTFONE9Jdm8zcUVRakVGeDMwb0pXdXdfUkVDQWNXdkFaTVQ2eE94eVZRYkdzMnJJcDBDeUlQOHNQOGJLRURRZjBGUFpucVRWbzMwcUZJ?oc=5","date":"2020-03-31","type":"regulatory","source":"respiratory-therapy.com","summary":"FDA Clears ABM Respiratory Care’s BiWaze Cough System - respiratory-therapy.com","headline":"FDA Clears ABM Respiratory Care’s BiWaze Cough System - respiratory","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}